Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Tendon Tissue Engineering: Pathophysiological Mechanism and Bioengineering Therapy of Tendinopathy

Chen B., Zhao Y., Guo S., Tang C., Xu B., Zhou M.

Narrative Review on Tendon Injury, published in Int J Nanomedicine (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Int J Nanomedicine (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41127789
PMCID
PMC12538227
DOI
10.2147/ijn.s550439
Citations
2

Abstract (original English)

Tendinopathy afflicts many professional athletes and the elderly. However, due to the unique cellular and histological composition of tendons, healing is frequently unsatisfactory. The clinical physical therapy and surgical interventions often fail to meet patient expectations. In recent years, bioengineering technology has undergone rapid development, with a significant number of studies in the biological field focusing on bioengineering technology to explore emerging treatments for diseases. Therefore, bioengineering technology has the potential to become an important part of future tendon healing therapies. The present article will describe the sources of scaffolds, biological factors and bioengineering strategies, with a focus on their current applications in laboratory and clinical contexts.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
TendonsAnimalsHumansTissue EngineeringTendinopathyTissue ScaffoldsBioengineering

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research